Inovio Hit With Shareholder Derivative Suit Over Coronavirus Vaccine Claims
PHILADELPHIA — Two biopharmaceutical company investors filed a shareholder derivative lawsuit against the company’s board of directors on June 15 in Pennsylvania federal court, alleging that the defendants breached their fiduciary...To view the full article, register now.
Already a subscriber? Click here to view full article